Cibus, Inc. (CBUS)
Automate Your Wheel Strategy on CBUS
With Tiblio's Option Bot, you can configure your own wheel strategy including CBUS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CBUS
- Rev/Share 0.1355
- Book/Share 2.1099
- PB 0.7731
- Debt/Equity 0.5072
- CurrentRatio 1.2318
- ROIC -0.8828
- MktCap 50641908.0
- FreeCF/Share -2.3404
- PFCF -0.6173
- PE -0.1977
- Debt/Assets 0.1064
- DivYield 0
- ROE -2.0318
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
USDA Designates Cibus' Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA's Biotechnology Regulations
Published: June 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
This action follows the USDA's recent designation of Cibus' disease resistance traits in Canola as not regulated, continuing Cibus' product development momentum in the globally important Canola crop This action follows the USDA's recent designation of Cibus' disease resistance traits in Canola as not regulated, continuing Cibus' product development momentum in the globally important Canola crop
Read More
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering
Published: June 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced the pricing of its previously announced public offering of 15,714,285 shares of its Class A Common Stock, at a purchase price of $1.75 per share, including to institutional and strategic investors, as well as the Chairman of Cibus' board of directors (5,714,286 shares).
Read More
Ecuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional Breeding
Published: May 07, 2025 by: GlobeNewsWire
Sentiment: Neutral
Designation confirms conventional regulation of Cibus herbicide tolerance traits in Rice in Ecuador paving the way for further product development and eventual commercialization in a key Rice growing region Designation confirms conventional regulation of Cibus herbicide tolerance traits in Rice in Ecuador paving the way for further product development and eventual commercialization in a key Rice growing region
Read More
Cibus (CBUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Negative
Cibus (CBUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola
Published: March 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
Initial bioassay data for Cibus' third mode of action for white mold (Sclerotinia) resistance trait in canola shows promising results in controlled environment assessment
Read More
Cibus Announces Important Update to Rice Gene Editing Conversion Rates
Published: February 14, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today issued a correction relating to the rice conversion rates previously disclosed in its January 16, 2025 press release. The Company has concluded that the gene editing conversion rates of 10-25% in Rice have not been reconfirmed based upon subsequent experiments and high variability in the conversion rate data.
Read More
About Cibus, Inc. (CBUS)
- IPO Date 2017-07-20
- Website https://www.cibus.com
- Industry Biotechnology
- CEO Dr. Peter R. Beetham B.Sc., Ph.D.
- Employees 157